Abstract

The Japanese breast cancer society clinical practice guidelines for pathological diagnosis of breast cancer, 2022 edition.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
The Japanese Breast Cancer Society Clinical Practice Guidelines for surgical treatment of breast cancer, 2022 edition.
Goro Kutomi ... Koichi Tomita
Breast cancer (Tokyo, Japan) | VOL. 31
Goro Kutomi, et. al.Goro Kutomi ... Koichi Tomita
16 Oct 2023
The Japanese Breast Cancer Society Clinical Practice Guidelines for systemic treatment of breast cancer, 2018 edition
Kei Koizumi ... Toshiro Mizuno
Breast Cancer | VOL. 27
Kei Koizumi, et. al.Kei Koizumi ... Toshiro Mizuno
02 Apr 2020
The Japanese Breast Cancer Society Clinical Practice Guideline for radiation treatment of breast cancer, 2018 edition
Hiroji Iwata ... Naoko Sanuki
Breast Cancer | VOL. 27
Hiroji Iwata, et. al.Hiroji Iwata ... Naoko Sanuki
28 Oct 2019
The Japanese Breast Cancer Society Clinical Practice Guidelines for systemic treatment of breast cancer, 2022 edition
...
Breast Cancer | VOL. 30
, et. al. ...
07 Oct 2023
View more papers

More From: Breast cancer (Tokyo, Japan)

Paper Title
Journal
Date
Author
A novel nomogram and survival analysis for different lymph node status in breast cancer based on the SEER database.
Lizhi Teng ... Weiyang Tao
Breast cancer (Tokyo, Japan) | VOL. -
Lizhi Teng, et. al.Lizhi Teng ... Weiyang Tao
27 May 2024
Assessing the effectiveness of high frequency repetitive transcranial magnetic stimulation for post-mastectomy pain in breast cancer patients: A randomized controlled trial.
Monika Kataria ... Renu Bhatia
Breast cancer (Tokyo, Japan) | VOL. -
Monika Kataria, et. al.Monika Kataria ... Renu Bhatia
26 May 2024
A randomized trial of the impact of symptom monitoring using an electronic patient-reported outcome app on health-related quality of life in postmenopausal breast cancer patients receiving adjuvant endocrine therapy.
Hiromi Okuyama ... Seigo Nakamura
Breast cancer (Tokyo, Japan) | VOL. -
Hiromi Okuyama, et. al.Hiromi Okuyama ... Seigo Nakamura
26 May 2024
Antitumor effects of co-treatment of resveratrol with antitumor drugs in ER- and HER2-positive breast cancer cells are due to induction of apoptosis and modulation of estrogen receptor expression.
Beatriz Tinoco Franceschi ... Maria Regina Torqueti
Breast cancer (Tokyo, Japan) | VOL. -
Beatriz Tinoco Franceschi, et. al.Beatriz Tinoco Franceschi ... Maria Regina Torqueti
23 May 2024
View more papers